Decision on optimal combinatorinal Therapies in IMIDS using Systems approaches
On October 9th, a significant milestone in the field of Immune-Mediated Inflammatory Diseases (IMIDs) research is set to unfold—the DoCTIS Project’s online General Assembly. This assembly, involving partners from Spain, Sweden, Italy, Germany, the UK, and the USA, marks a
Barcelona, Spain, witnessed a pivotal meeting of partners on September 26th, where they gathered to discuss the trials and analysis strategy. With candidates for the clinical trial already in the pipeline, the partners’ collaborative efforts aim to advance research and
DOCTIS has organised a symposium event focused on “Combination therapies in common diseases: clinical and translational challenges”. This event will be held the 7th of October 2021, free of charge, online and will start at 5 p.m CET.
The 20th January the eight European partners and one USA partner that constitute the DoCTIS Consortium held the kick-off meeting at the Vall Hebron University Hospital (VHIR).